Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdosesBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32022-05-132OAAI
Adapting treatment length to opioid-dependent individuals' needs and preferences: a 2-year follow-up to a 1-year study of extended-release naltrexoneADDICTIONIF5.32021-01-209OAAI
No Increase in Chronic Pain Among Opioid-Dependent Individuals Randomized to Treatment With Extended-Release Naltrexone Compared to Buprenorphine-NaloxoneBIOLOGICAL PSYCHIATRYIF92019-05-011PREAI
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trialADDICTIONIF5.32018-06-2227OAAI
The Effectiveness of Injectable Extended Release Naltrexone Versus Daily Buprenorphine-Naloxone for Opioid Dependence in Short and Long Term TreatmentBIOLOGICAL PSYCHIATRYIF92018-05-014PREAI
Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experienceJOURNAL OF PUBLIC HEALTHIF3.12015-10-2730OA
Effects of Hemodialysis on Methadone Pharmacokinetics and QTcCLINICAL THERAPEUTICSIF3.62015-07-015PREAI
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient miceJOURNAL OF EXPERIMENTAL MEDICINEIF10.61999-10-04362OAAI
Secretory component mRNA and protein expression in colorectal adenomas and carcinomasBRITISH JOURNAL OF CANCERIF6.81996-06-0113OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向